Results 61 to 70 of about 28,817 (265)
JACC: Case Reports, 2020 Cardiac amyloidosis is a progressive disorder and is sometimes difficult to diagnose even when suspected in the appropriate clinical setting. We present an interesting case of rapidly progressive light-chain cardiac amyloidosis and highlights the importance of close monitoring even when the initial biopsy and imaging findings are not pathognomonic for ...
Adam Castaño, Mathew S. Maurer
openaire +3 more sources
Non‐cardiac biopsy sites with high frequency of transthyretin amyloidosis
ESC Heart Failure, 2021 Aims Cardiac scintigraphy, a non‐invasive technique for diagnosing ATTR cardiac amyloidosis, lacks specificity in patients with concomitant monoclonal gammopathy (up to 40% of cases).
Surendra Dasari +10 more
doaj +1 more source
Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis – a retrospective Austrian multicenter study [PDF]
, 2022 Nicolas Verheyen +14 more
openalex +1 more source
European Journal of Heart Failure, EarlyView.Proposed algorithm to screen for transthyretin cardiac amyloidosis (ATTR‐CA). AL‐CA, immunoglobulin light‐chain cardiac amyloidosis; AMYLI, AMYLoidosis Index; AUC, area under the curve; IWT, increased wall thickness; LVEF, left ventricular ejection fraction; PYP, pyrophosphate.
Giovanni Battista Bonfioli +11 more
wiley +1 more source
Right Ventricular Endocardial Mapping and a Potential Arrhythmogenic Substrate in Cardiac Amyloidosis—Role of ICD [PDF]
, 2021 Aleksandra Liżewska-Springer +6 more
openalex +1 more source
A thousand words about the imaging in cardiac amyloidosis
Journal of Medical Science, 2019 Cardiac amyloidosis is an infiltrative disease which usually occurs under the form of restrictive cardiomyopathy. Advances in the treatment have changed the unfavorable outcomes of this disease. Thus, early diagnosis is essential.
Rafał Dankowski +3 more
doaj +1 more source
Cardiac Failure Review, 2020 Heart failure with preserved ejection fraction (HFpEF) comprises half of the heart failure population. A specific, but underdiagnosed, cause for HFpEF is transthyretin-derived (ATTR) amyloidosis.
Sebastiaan HC Klaassen +5 more
doaj +1 more source
[Cardiac arrhythmias and amyloidosis].
Archivos peruanos de cardiologia y cirugia cardiovascular, 2022 Cardiac amyloidosis (CA) is a form of cardiomyopathy characterized by the extracellular deposit of protein fibers in the myocardium, leading to the development of heart failure, arrhythmias, and electrical conduction system alterations. It is known that most cardiomyopathies have a close relationship with heart rhythm abnormalities, however, CA is ...
Salinas-Arce, Jorge +6 more
openaire +2 more sources
European Journal of Heart Failure, EarlyView.Long‐term efficacy of tafamidis in patients with ATTR‐CM in ATTR‐ACT and its LTE by NAC stage at ATTR‐ACT baseline. ATTR‐ACT, Tafamidis in Transthyretin Cardiomyopathy Clinical Trial; ATTR‐CM, transthyretin amyloid cardiomyopathy; NAC, National Amyloidosis Centre.
Thibaud Damy +4 more
wiley +1 more source